AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021
21 Aprile 2021 - 10:05PM
Business Wire
AbCellera (Nasdaq: ABCL) will announce its first-quarter 2021
financial results on Thursday, May 13, 2021 and hold an earnings
conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
the same day.
A live webcast will be available on AbCellera’s Investor
Relations website at: https://investors.abcellera.com/. Replay of
the webcast will be available through the same link following the
conference call.
About AbCellera
AbCellera is a technology company that searches, decodes, and
analyzes natural immune systems to find antibodies that its
partners can develop into drugs to prevent and treat disease.
AbCellera partners with drug developers of all sizes, from large
pharmaceutical to small biotechnology companies, empowering them to
move quickly, reduce cost, and tackle the toughest problems in drug
development. To learn more, please visit www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210421005994/en/
Media: Jessica Yingling, Ph.D.; media@abcellera.com,
+1(236)521-6774 Investor Relations: Melanie Solomon;
ir@abcellera.com, +1(778)729-9116
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Lug 2023 a Lug 2024